All News

The University of Colorado is trying to recruit patients on the internet for a trial to test ponatinib in a rare form of lung cancer.

Pembrolizumab was expected to be approved by October, but the turnaround might be much earlier.

While all states have Medicaid, not all Medicaid programs have the same benefits. A study published today in Cancer, the journal of the American Cancer Society, examined how differences in reimbursement for office visits and for screenings themselves play out in the percentages of patients who are screened for common cancers.

The study, conducted in cynomolgus monkeys, explored several candidate vaccines from NIAID's preclinical services program.

The service is aimed to provide the state's first online service to treat common medical conditions.

The lawsuit, which was a long time coming, names top executives within Oracle, and claims damages as much as 240 million and penalties as high as $480 million for each allegation of wrongdoing.

Millions helped by Obama health law may get hit with reduced tax refunds unless they act soon.

Access to prices and just a bit of nudging seems to not only help members find the best deals on elective health services like imaging but also spur some competition among providers.

Over a five-year period, five programs sponsored by Blue Cross Blue Shield of Michigan and Blue Care Network to improve the quality of certain medical and surgical procedures performed in Michigan hospitals, have produced $597 million in healthcare cost savings, and have lowered complication and mortality rates for thousands of patients.

The study presented at the American Academy of Dermatology meeting evaluated some of the risk factors associated with the skin disease and it's treatment and the incidence of melanoma and lymphoma.

In 2003, when President George W. Bush signed the major Medicare expansion that would establish prescription drug coverage, he called it "a promise, a solemn promise, to America's seniors."

With the FDA accepting an application from Sandoz for it's biosimilar filgrastim, the biosimilar landscape in the US is expected to undergo a huge turnaround.

Triumeq(R), the first-ever single pill triple drug combination against HIV, was approved absed on the results of 2 clinical trials.

Todd Park, well-known in healthcare IT circles as a founder of Athenahealth and Castlight Health, is leaving his post as White House chief technology officer by year-end, Fortune is reporting..

Apple's iPhone 6 is just weeks from release and will kick off Apple's new health care strategy. Google's working on its own plan to chase the health care market too.

The heavily criticized Medicare two-midnights rule involving short inpatient stays has technically been in effect for the past year.

The Obama administration will offer a new accommodation to religious nonprofits that object to covering birth control for their employees. The measure allows those groups to notify the government, rather than their insurance company, that birth control violates their religious beliefs.

The study, published in Diabetes Care, evaluated patients who participated in the NIH-sponsored Look AHEAD program.

75 percent of those at high risk for BRCA mutations have no idea they may have increased chance of ovarian cancer, drawing attention to the importance of genetic counseling.

How much leeway do employers and insurers have in deciding whether they'll cover contraceptives without charge and in determining which methods make the cut?

In the twilight of his term of office, Kentucky Gov. Steve Beshear is savoring the political fruits from a leap of faith made 15 months ago, when he spurned his Legislature and opted to expand Medicaid, citing a unique provision in Kentucky regulations. A year after the CMS visit, Beshear and his team are the subject of glowing reports, which describe how a commonwealth with a history of getting things wrong in healthcare has done just about everything right in Obamacare.

An innovative method for using affordable, consumer-grade 3D printers and materials has been developed to fabricate custom medical implants that can contain antibacterial and chemotherapeutic compounds for targeted drug delivery.

The test, the first-ever to distinguish the type 1 form of diabetes, could detect the ZnT8 autoantibody in 65 percent of the samples from patients with diagnosed type 1 diabetes and gave false positive results in less than two percent of the samples from patients diagnosed with other disease.

The panel, based on next-generation sequencing, will help select the target population - to deliver precision medicine and improve outcomes.

Increased compensation was reported by 68 percent of specialties, with gastroenterology, cardiac/thoracic surgery, emergency medicine, and neurology taking the lead.